Active, not recruitingInterventional · Phase 1/2NCT04068194 ↗A Phase I/II Study of M3814 and Avelumab in Combination With Hypofractionated Radiation in Patients With Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies